Showing 141-150 of 271 results for "".
Recent Developments
https://practicaldermatology.com/columns/recent-developments/recent-developments/21186/Recent Developments
https://practicaldermatology.com/columns/recent-developments/PD0509_05-php/22827/Recent Developments
https://practicaldermatology.com/columns/recent-developments/PD0409_05-php/22843/DermWireTV: Spevigo for GPP; Derms on Acne Experience; IFPA Takes PsO to the Gaming World; La Roche-Posay at the US Open
https://practicaldermatology.com/topics/skin-cancer-photoprotection/dermwiretv-spevigo-for-gpp-derms-on-acne-experience-ifpa-takes-pso-to-the-gaming-world-la-roche-posay-at-the-us-open/20136/Boehringer Ingelheim’s Spevigo is the first FDA-approved treatment option for generalized pustular psoriasis (GPP) flares in adults. Spesolimab is a novel, selective antibody that blocks the activation of the interleukin-36 receptor. Dermatologists, dermatology physician assistants, and dermatologyYour Comprehensive Guide to Energy-Based Devices
https://practicaldermatology.com/topics/practice-management/your-comprehensive-guide-to-energy-based-devices/23146/Therapeutic Review: A Host of New Treatments Emerged in 2018
https://practicaldermatology.com/topics/psoriasis/therapeutic-review-a-host-of-new-treatments-emerged-in-2018/20381/Here's a handy reference to new drugs and devices—and other key developments—this year.Recent Developments
https://practicaldermatology.com/columns/recent-developments/recent-developments/20533/Femilift For the Treatment of Vaginal Health and Sexual Function: A Pilot Study
https://practicaldermatology.com/topics/general-topics/femilift-for-the-treatment-of-vaginal-health-and-sexual-function-a-pilot-study/20703/Your Comprehensive Guide to Energy-Based Devices
https://practicaldermatology.com/topics/aesthetics-cosmeceuticals/your-comprehensive-guide-to-energy-based-devices-1/23334/Recent Developments
https://practicaldermatology.com/columns/recent-developments/recent-developments/20730/